The turnover per employee for Biotechnology Research and Experimental Development in Germany has shown a consistent growth trajectory over the forecasted period from 2024 to 2028, starting at 178.2 thousand Euros in 2024 and reaching 204.2 thousand Euros by 2028. This translates to an annual average increase (CAGR) of approximately 3.5% over these five years.
The year-on-year variations depict steady gains with around 3.6% growth in 2025, 3.5% in 2026, 3.4% in 2027, and 3.3% in 2028. The turnover per employee in 2023 was 172.3 thousand Euros, indicating an upward trend starting from this base year.
Future trends to watch for include increased investment in R&D, potential policy changes impacting the biotech sector, and the integration of advanced technologies such as AI and machine learning which could drive productivity and efficiency further, enhancing turnover per employee growth.
